BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15574803)

  • 1. Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.
    Kahler CM; Datta A; Tzeng YL; Carlson RW; Stephens DS
    Glycobiology; 2005 Apr; 15(4):409-19. PubMed ID: 15574803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis.
    Tzeng YL; Datta A; Ambrose K; Lo M; Davies JK; Carlson RW; Stephens DS; Kahler CM
    J Biol Chem; 2004 Aug; 279(33):35053-62. PubMed ID: 15173178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent.
    Rahman MM; Stephens DS; Kahler CM; Glushka J; Carlson RW
    Carbohydr Res; 1998 Feb; 307(3-4):311-24. PubMed ID: 9675370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-Acetylation of the terminal N-acetylglucosamine of the lipooligosaccharide inner core in Neisseria meningitidis. Influence on inner core structure and assembly.
    Kahler CM; Lyons-Schindler S; Choudhury B; Glushka J; Carlson RW; Stephens DS
    J Biol Chem; 2006 Jul; 281(29):19939-48. PubMed ID: 16687398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK).
    Kahler CM; Carlson RW; Rahman MM; Martin LE; Stephens DS
    J Bacteriol; 1996 Mar; 178(5):1265-73. PubMed ID: 8631701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the lipooligosaccharide (LOS) from the alpha-1,2-N-acetyl glucosamine transferase (rfaK(NMB)) mutant strain CMK1 of Neisseria meningitidis: implications for LOS inner core assembly and LOS-based vaccines.
    Rahman MM; Kahler CM; Stephens DS; Carlson RW
    Glycobiology; 2001 Aug; 11(8):703-9. PubMed ID: 11479281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides.
    Schwingel JM; St Michael F; Cox AD; Masoud H; Richards JC; Campagnari AA
    Glycobiology; 2008 Jun; 18(6):447-55. PubMed ID: 18337458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoethanolamine is located at the 6-position and not at the 7-position of the distal heptose residue in the lipopolysaccharide from Neisseria meningitidis.
    St Michael F; Vinogradov E; Wenzel CQ; McIntosh B; Li J; Hoe JC; Richards JC; Cox AD
    Glycobiology; 2009 Dec; 19(12):1436-45. PubMed ID: 19666923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.
    Choudhury B; Kahler CM; Datta A; Stephens DS; Carlson RW
    Carbohydr Res; 2008 Nov; 343(17):2971-9. PubMed ID: 18804756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB.
    Lee FK; Stephens DS; Gibson BW; Engstrom JJ; Zhou D; Apicella MA
    Infect Immun; 1995 Jul; 63(7):2508-15. PubMed ID: 7790063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity.
    Ram S; Cox AD; Wright JC; Vogel U; Getzlaff S; Boden R; Li J; Plested JS; Meri S; Gulati S; Stein DC; Richards JC; Moxon ER; Rice PA
    J Biol Chem; 2003 Dec; 278(51):50853-62. PubMed ID: 14525973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.
    Mistretta N; Seguin D; Thiébaud J; Vialle S; Blanc F; Brossaud M; Talaga P; Norheim G; Moreau M; Rokbi B
    J Biol Chem; 2010 Jun; 285(26):19874-83. PubMed ID: 20421293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.
    Kahler CM; Carlson RW; Rahman MM; Martin LE; Stephens DS
    J Bacteriol; 1996 Dec; 178(23):6677-84. PubMed ID: 8955282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
    Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
    J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene.
    Zhou D; Stephens DS; Gibson BW; Engstrom JJ; McAllister CF; Lee FK; Apicella MA
    J Biol Chem; 1994 Apr; 269(15):11162-9. PubMed ID: 8157643
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Tzeng YL; Sannigrahi S; Borrow R; Stephens DS
    Front Immunol; 2024; 15():1350344. PubMed ID: 38440731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-variation of the truncated lipo-oligosaccharide of Neisseria meningitidis NMB phosphoglucomutase isogenic mutant NMB-R6.
    Monteiro MA; Fortuna-Nevin M; Farley J; Pavliak V
    Carbohydr Res; 2003 Nov; 338(24):2905-12. PubMed ID: 14667712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
    Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
    Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis.
    Plested JS; Makepeace K; Jennings MP; Gidney MA; Lacelle S; Brisson J; Cox AD; Martin A; Bird AG; Tang CM; Mackinnon FM; Richards JC; Moxon ER
    Infect Immun; 1999 Oct; 67(10):5417-26. PubMed ID: 10496924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.